Skip to main content
. 2013 May 2;178(4):610–624. doi: 10.1093/aje/kwt007

Table 4.

Associations of Dietary OBS Measures With Incident, Sporadic Colorectal Adenoma According to Lifestyle OBS in Pooled Data From 3 Case-Control Studies (CPRU Study, 1991–1994; MAP I Study, 1994–1997; and MAP II Study, 2002)

Dietary OBSa Lifestyle OBS
Tertile 1
Tertile 2
Tertile 3
No. of Cases RRb 95% CI No. of Cases RRb 95% CI No. of Cases RRb 95% CI
OBS–equal weight  
 Tertile 1 160 1.00 Referent 93 1.00 Referent 67 1.00 Referent
 Tertile 2 117 0.78 0.55, 1.10 69 0.92 0.61, 1.36 50 0.47 0.30, 0.76
 Tertile 3 99 0.90 0.62, 1.32 86 0.91 0.62, 1.39 48 0.56 0.35, 0.91
  Ptrend 0.51 0.66 0.02
OBS–lit. review  
 Tertile 1 180 1.00 Referent 57 1.00 Referent 46 1.00 Referent
 Tertile 2 156 0.69 0.50, 1.96 77 1.16 0.76, 1.77 50 1.10 0.68, 1.80
 Tertile 3 108 0.51 0.35, 0.73 69 1.12 0.72, 1.72 46 0.83 0.50, 1.38
  Ptrend <0.001 0.63 0.49
OBS–a posteriori  
 Tertile 1 188 1.00 Referent 93 1.00 Referent 52 1.00 Referent
 Tertile 2 121 0.82 0.58, 1.15 72 0.81 0.54, 1.22 52 0.72 0.44, 1.17
 Tertile 3 95 0.65 0.45, 0.93 74 1.01 0.66, 1.54 42 0.58 0.35, 0.98
  Ptrend 0.02 0.99 0.04
OBS–Bayesian  
 Tertile 1 197 1.00 Referent 72 1.00 Referent 50 1.00 Referent
 Tertile 2 133 0.89 0.63, 1.24 57 0.70 0.45, 1.07 56 1.06 0.66, 1.70
 Tertile 3 108 0.63 0.45, 0.89 76 0.96 0.63, 1.45 40 0.83 0.50, 1.39
  Ptrend 0.01 0.87 0.49

Abbreviations: CI, confidence interval; CPRU, Cancer Prevention Research Unit; MAP, Markers of Adenomatous Polyps; OBS, oxidative balance score; RR, relative risk.

a OBS–equal weight: all OBS components received equal weights; OBS–lit. review: weights for OBS components were based on effect estimates derived from literature review; OBS–a posteriori: weights for OBS components were based on CPRU Study data; OBS–Bayesian: weights for OBS components were based on Bayesian analysis of case-control data. Tertiles for OBS are sex-specific, and the dietary components were adjusted for total energy intake.

b Adjusted for age, sex, education, family history of colorectal cancer in a first-degree relative, regular aspirin use, regular use of nonsteroidal antiinflammatory drugs, total calcium intake, total vitamin D intake, total energy intake, total folate intake, dietary fiber intake, and hormone therapy (among women).